Wednesday, April 19, 2017 9:23:38 PM
biotechs trade at 30x earnings or 5x gross sales or 15x net sales or on air if they are a r and d company, with VDRM we have sales coming this year here is the analysis broken down below
ie...from the 500,000 bottles alone will yield $62.5M gross sales
$62.5m in gross sales X 5x gross sales = 325m market cap = $1.00 - $1.50 target
OR
62.5m in gross sales @ a 50% margin = $31m in net sales X 15x net sales = 450m market cap = $2.00 + target
OR
62.5m in gross sales with a $31m in net sales which divided by outstanding stock = 0.15 cents earnings X 30x earnings (pe - price to earnings) = $4.50 + target
Wytec Wins Multi-State Government Contract for AI Gunshot Detection • WYTC • Feb 3, 2025 7:16 AM
UAV Corp. Retains Legal Counsel to Address Legacy Debt from HTTI Era; 500 Million Authorized Shares Confirmed - UAV Corp. Delivers on Strategic Commitments • UMAV • Jan 31, 2025 1:30 PM
VAYK Closes Acquisition of $1 Million Company • VAYK • Jan 30, 2025 9:52 AM
C2 Blockchain Inc. Secures Regulation A Approval, Prepares to Launch Bitcoin Mining Operations • CBLO • Jan 30, 2025 8:00 AM
Swifty Global Announces Signing of Share Purchase Agreement to be Acquired by Signing Day Sport (NYSE AMERICAN: SGN) • DRCR • Jan 29, 2025 11:19 AM
UAV Corp. Revolutionizes Surveillance with AI-Powered Skyborne enhanced WAMI Technology • UMAV • Jan 28, 2025 1:30 PM